| Title : Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment - Komloova_2011_Bioorg.Med.Chem.Lett_21_2505 |
| Author(s) : Komloova M , Musilek K , Horova A , Holas O , Dohnal V , Gunn-Moore F , Kuca K |
| Ref : Bioorganic & Medicinal Chemistry Lett , 21 :2505 , 2011 |
|
Abstract :
This paper describes the preparation and in vitro evaluation of 18 newly prepared bis-quinolinium inhibitors on human recombinant acetylcholinesterase (AChE) and human plasmatic butyrylcholinesterase (BChE). Their inhibitory (IC(50)) and was compared to the chosen standards ambenonium dichloride, edrophonium chloride, BW284c51 and ethopropazine hydrochloride. One novel compound was found to be a promising inhibitor of hAChE (in nM range) and was better than edrophonium chloride or BW284c51, but was worse than ambenonium chloride. This compound also showed selectivity towards hAChE and it was confirmed as a non-competitive inhibitor of hAChE by kinetic analysis. A molecular modelling study further confirmed its binding to the peripheral active site of hAChE via apparent pi-pi or pi-cationic interactions. |
| PubMedSearch : Komloova_2011_Bioorg.Med.Chem.Lett_21_2505 |
| PubMedID: 21397501 |
Komloova M, Musilek K, Horova A, Holas O, Dohnal V, Gunn-Moore F, Kuca K (2011)
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment
Bioorganic & Medicinal Chemistry Lett
21 :2505
Komloova M, Musilek K, Horova A, Holas O, Dohnal V, Gunn-Moore F, Kuca K (2011)
Bioorganic & Medicinal Chemistry Lett
21 :2505